Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria

Summary

This study is a randomized, controlled, single-center clinical study to evaluate the short-term efficacy of low-dose Interleukin-2 injection as an add-on therapy for the treatment of patients aged 18-75 who have been diagnosed with CSU and remain symptomatic despite oral antihistamine treatment .

Timeline

Start

2021-06-16

Primary completion

2022-06-01

Completion

2022-12-01

Drugs

Indications